Search Results - "Gocek, Elzbieta"

Refine Results
  1. 1

    Cardiovascular risk and metabolic profile of Polish citizens from Lower Silesia. First signs of metabolic crisis? by Kozera, Lukasz, Kuliczkowski, Wiktor, Gocek, Elzbieta

    Published in Archives of medical science (2022)
    “…Population biobanks are essential for the development of public health screening and improvement of personalized medicine. Since 2012, Biobank of Łukasiewicz…”
    Get full text
    Journal Article
  2. 2

    Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells by Gocek, Elzbieta, Moulas, Anargyros N., Studzinski, George P.

    “…Abstract Protein tyrosine kinases (PTKs) are enzymes that transfer phosphate groups to tyrosine residues on protein substrates. Phosphorylation of proteins…”
    Get full text
    Journal Article
  3. 3

    Differentiation therapy of acute myeloid leukemia by Gocek, Elzbieta, Marcinkowska, Ewa

    Published in Cancers (16-05-2011)
    “…Acute Myeloid Leukemia (AML) is a predominant acute leukemia among adults, characterized by accumulation of malignantly transformed immature myeloid…”
    Get full text
    Journal Article Book Review
  4. 4

    The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy by Gocek, Elzbieta, Studzinski, George P

    Published in Journal of clinical medicine (25-03-2015)
    “…The current standard regimens for the treatment of acute myeloid leukemia (AML) are curative in less than half of patients; therefore, there is a great need…”
    Get full text
    Journal Article
  5. 5
  6. 6

    MicroRNA-32 Upregulation by 1,25-Dihydroxyvitamin D3 in Human Myeloid Leukemia Cells Leads to Bim Targeting and Inhibition of AraC-Induced Apoptosis by GOCEK, Elzbieta, XUENING WANG, XIUPING LIU, LIU, Chang-Gong, STUDZINSKI, George P

    Published in Cancer research (Chicago, Ill.) (01-10-2011)
    “…1,25-Dihydroxyvitamin D(3) (1,25D) used to treat human acute myeloid leukemia (AML) cells induces features of normal monocytes, but the mechanisms underlying…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Regulation of Leukemic Cell Differentiation through the Vitamin D Receptor at the Levels of Intracellular Signal Transduction, Gene Transcription, and Protein Trafficking and Stability by Gocek, Elżbieta, Baurska, Hanna, Marchwicka, Aleksandra, Marcinkowska, Ewa

    Published in Leukemia Research and Treatment (01-01-2012)
    “…1α,25-Dihydroxyvitamin D3 (1,25(OH)2D) exerts its biological activities through vitamin D receptor (VDR), which is a member of the superfamily of steroid…”
    Get full text
    Journal Article
  9. 9

    MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3 by Wang, Xuening, Gocek, Elzbieta, Liu, Chang-Gong, Studzinski, George P.

    Published in Cell cycle (Georgetown, Tex.) (01-03-2009)
    “…Human myeloid leukemia cells exposed to 1,25-dihydroxyvitamin D3 (1,25D), a major cancer chemopreventive agent, acquire features of normal monocytes and arrest…”
    Get full text
    Journal Article
  10. 10

    NADPH-cytochrome P450 reductase is regulated by all-trans retinoic acid and by 1,25-dihydroxyvitamin D3 in human acute myeloid leukemia cells by Gocek, Elżbieta, Marchwicka, Aleksandra, Bujko, Kamila, Marcinkowska, Ewa

    Published in PloS one (18-03-2014)
    “…Acute myeloid leukemia (AML) cell lines can be driven to differentiate to monocyte-like cells by 1,25- dihydroxyvitamin D3 (1,25D) and to granulocyte-like…”
    Get full text
    Journal Article
  11. 11

    DNA Repair in Despair-Vitamin D Is Not Fair by Gocek, Elżbieta, Studzinski, George P.

    Published in Journal of cellular biochemistry (01-08-2016)
    “…ABSTRACT The role of vitamin D as a treatment option for neoplastic diseases, once considered to have a bright future, remains controversial. The preclinical…”
    Get full text
    Journal Article
  12. 12

    Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiation by Gocek, Elżbieta, Marchwicka, Aleksandra, Baurska, Hanna, Chrobak, Agnieszka, Marcinkowska, Ewa

    “…► We study effects of 1,25-dihydroxyvitamin D3 and of ATRA toward AML cell lines. ► KG-1 cells appear resistant to 1,25-dihydroxyvitamin D3, but susceptible to…”
    Get full text
    Journal Article
  13. 13

    Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation by Gocek, Elżbieta, Kiełbiński, Marek, Marcinkowska, Ewa

    Published in FEBS letters (01-05-2007)
    “…1,25-Dihydroxyvitamin D 3 (1,25D) regulates gene transcription through the nuclear vitamin D receptor (VDR) and initiates rapid cellular responses via an…”
    Get full text
    Journal Article
  14. 14

    Heat shock protein 90 interacts with vitamin D receptor in human leukemia cells by Marcinkowska, Ewa, Gocek, Elżbieta

    “…The active form of vitamin D, 1α,25-dihydroxyvitamin D 3 (1,25D), has a broad range of effects which are mediated by nuclear vitamin D receptor (VDR). Many…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    Different susceptibilities to 1,25-dihydroxyvitamin D3 -induced differentiation of AML cells carrying various mutations by Gocek, Elżbieta, Kiełbiński, Marek, Baurska, Hanna, Haus, Olga, Kutner, Andrzej, Marcinkowska, Ewa

    Published in Leukemia research (01-05-2010)
    “…Abstract This study was designed to compare the differentiation-inducing potential of 1,25-dihydroxyvitamin D3 (1,25D) with some analogs (VDAs) in a panel of…”
    Get full text
    Journal Article
  16. 16

    Different susceptibilities to 1,25-dihydroxyvitamin D 3-induced differentiation of AML cells carrying various mutations by Gocek, Elżbieta, Kiełbiński, Marek, Baurska, Hanna, Haus, Olga, Kutner, Andrzej, Marcinkowska, Ewa

    Published in Leukemia research (01-05-2010)
    “…This study was designed to compare the differentiation-inducing potential of 1,25-dihydroxyvitamin D 3 (1,25D) with some analogs (VDAs) in a panel of acute…”
    Get full text
    Journal Article
  17. 17

    Vitamin D and differentiation in cancer by Gocek, Elzbieta, Studzinski, George P.

    “…This paper reviews the current understanding of the vitamin D-induced differentiation of neoplastic cells, which results in the generation of cells that…”
    Get full text
    Journal Article
  18. 18

    Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential by Gocek, Elżbieta, Kiełbiński, Marek, Wyłób, Paulina, Kutner, Andrzej, Marcinkowska, Ewa

    Published in Steroids (22-12-2008)
    “…1,25-Dihydroxyvitamin D 3 (1,25D) regulates gene transcription through a nuclear vitamin D receptor (VDR) which acts as a ligand-regulated transcription…”
    Get full text
    Journal Article
  19. 19
  20. 20

    NADPH-Cytochrome P450 Reductase Is Regulated by All-Trans Retinoic Acid and by 1,25-Dihydroxyvitamin D.sub.3 in Human Acute Myeloid Leukemia Cells by Gocek, Elzbieta, Marchwicka, Aleksandra, Bujko, Kamila, Marcinkowska, Ewa

    Published in PloS one (18-03-2014)
    “…Acute myeloid leukemia (AML) cell lines can be driven to differentiate to monocyte-like cells by 1,25- dihydroxyvitamin D.sub.3 (1,25D) and to granulocyte-like…”
    Get full text
    Journal Article